Finance Wales-backed Creo Medical raises $8.45m
Welsh electrosurgery devices manufacturer Creo Medical has raised $8.45m from Pentax Medical, as well as existing investors Finance Wales and the Angel CoFund.
Individual angel investors also participated in the round led by Japanese endoscopic imaging devices company Pentax Medical. The investment is the third round for Creo Medical, bringing the total raised to $20.7m.
With the fresh cash in hand, Creo will continue working towards achieving US regulatory approval for its platform, as well as build on the company's current portfolio of intellectual property.
Previous funding
Finance Wales led the first investment in Creo, injecting £1.36m in May 2012. The VC followed up its investment with a £3.5m round in November 2014, alongside the Angel CoFund.
Company
Founded in 2003, Creo is a Chepstow-based designer and developer of an electrosurgery platform, as well as instruments for endoscopy and minimally invasive surgery.
People
Richard Thompson led the deal for Finance Wales. David Woods is the chief marketing officer of Pentax. Craig Gulliford is the CEO of Creo.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









